Search results
Amarin (NASDAQ:AMRN) shareholders have endured a 83% loss from investing in the stock three years...
Simply Wall St. via Yahoo Finance· 11 months agoIt's not possible to invest over long periods without making some bad investments. But really bad...
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 3 weeks agoAmarin Corporation Plc AMRN reported first-quarter 2024 adjusted loss of 2 cents per share, which...
Why Amarin (AMRN) Stock Might be a Great Pick
Zacks via Yahoo Finance· 2 years agoOne stock that might be an intriguing choice for investors right now is Amarin Corporation plc AMRN. This is because this security in the Medical -...
Amarin (AMRN) Q2 Earnings & Sales Hurt by Vazkepa Generics
Zacks via Yahoo Finance· 2 years agoAmarin's (AMRN) Vazkepa sales decline year over year amid rising generic competition and...
Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall
Zacks via Yahoo Finance· 1 year agoAmarin Corporation Plc AMRN reported first-quarter 2023 adjusted earnings of 2 cents per share, which beat the Zacks Consensus Estimate and our model...
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
Zacks via Yahoo Finance· 2 months agoAmarin (AMRN) secures a new patent for Vazkepa in Europe, which extends its exclusivity for eight...
Amarin (AMRN) Dips 16% on Layoff Plan & Preliminary Sales Miss
Zacks via Yahoo Finance· 10 months agoAmarin (AMRN) decides to initiate a restructuring plan to maximize cash flow opportunities in the...
Why Amarin Stock Was Rocketing Higher on Wednesday
Motley Fool via Yahoo Finance· 2 months agoAny one-product company that receives good news about that product will likely attract investors. That was the case Wednesday with Amarin (NASDAQ: AMRN),...
5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates
Zacks via Yahoo Finance· 3 months agoIt has been a rather lukewarm earnings season for the drug and biotech sector. Majority of large...
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More
Zacks via Yahoo Finance· 1 year agoQuite a few pharma and biotech bigwigs reported results last week, with the earnings picture looking...
